Sofia Zdunek
Karolinska Institutet
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sofia Zdunek.
Science | 2009
Olaf Bergmann; Ratan D. Bhardwaj; Samuel Bernard; Sofia Zdunek; Fanie Barnabé-Heider; Stuart Walsh; Joel Zupicich; Kanar Alkass; Bruce A. Buchholz; Henrik Druid; Stefan Jovinge; Jonas Frisén
It has been difficult to establish whether we are limited to the heart muscle cells we are born with or if cardiomyocytes are generated also later in life. We have taken advantage of the integration of carbon-14, generated by nuclear bomb tests during the Cold War, into DNA to establish the age of cardiomyocytes in humans. We report that cardiomyocytes renew, with a gradual decrease from 1% turning over annually at the age of 25 to 0.45% at the age of 75. Fewer than 50% of cardiomyocytes are exchanged during a normal life span. The capacity to generate cardiomyocytes in the adult human heart suggests that it may be rational to work toward the development of therapeutic strategies aimed at stimulating this process in cardiac pathologies.
Cell | 2015
Olaf Bergmann; Sofia Zdunek; Anastasia Felker; Mehran Salehpour; Kanar Alkass; Samuel Bernard; Staffan L. Sjostrom; Mirosława Szewczykowska; Teresa Jackowska; Cris dos Remedios; Torsten Malm; Michaela Andrä; Ramadan Jashari; Jens R. Nyengaard; Göran Possnert; Stefan Jovinge; Henrik Druid; Jonas Frisén
The contribution of cell generation to physiological heart growth and maintenance in humans has been difficult to establish and has remained controversial. We report that the full complement of cardiomyocytes is established perinataly and remains stable over the human lifespan, whereas the numbers of both endothelial and mesenchymal cells increase substantially from birth to early adulthood. Analysis of the integration of nuclear bomb test-derived (14)C revealed a high turnover rate of endothelial cells throughout life (>15% per year) and more limited renewal of mesenchymal cells (<4% per year in adulthood). Cardiomyocyte exchange is highest in early childhood and decreases gradually throughout life to <1% per year in adulthood, with similar turnover rates in the major subdivisions of the myocardium. We provide an integrated model of cell generation and turnover in the human heart.
Cell | 2014
Maggie S.Y. Yeung; Sofia Zdunek; Olaf Bergmann; Samuel Bernard; Mehran Salehpour; Kanar Alkass; Shira Perl; John F. Tisdale; Göran Possnert; Lou Brundin; Henrik Druid; Jonas Frisén
The myelination of axons by oligodendrocytes has been suggested to be modulated by experience, which could mediate neural plasticity by optimizing the performance of the circuitry. We have assessed the dynamics of oligodendrocyte generation and myelination in the human brain. The number of oligodendrocytes in the corpus callosum is established in childhood and remains stable after that. Analysis of the integration of nuclear bomb test-derived (14)C revealed that myelin is exchanged at a high rate, whereas the oligodendrocyte population in white matter is remarkably stable in humans, with an annual exchange of 1/300 oligodendrocytes. We conclude that oligodendrocyte turnover contributes minimally to myelin modulation in human white matter and that this instead may be carried out by mature oligodendrocytes, which may facilitate rapid neural plasticity.
Cell | 2009
Maria Genander; Michael M. Halford; Nan-Jie Xu; Malin Eriksson; Zuoren Yu; Zhaozhu Qiu; Anna Martling; Gedas Greicius; Sonal Thakar; Timothy Catchpole; Michael J. Chumley; Sofia Zdunek; Chenguang Wang; T. Holm; Stephen P. Goff; Sven Pettersson; Richard G. Pestell; Mark Henkemeyer; Jonas Frisén
Signaling proteins driving the proliferation of stem and progenitor cells are often encoded by proto-oncogenes. EphB receptors represent a rare exception; they promote cell proliferation in the intestinal epithelium and function as tumor suppressors by controlling cell migration and inhibiting invasive growth. We show that cell migration and proliferation are controlled independently by the receptor EphB2. EphB2 regulated cell positioning is kinase-independent and mediated via phosphatidylinositol 3-kinase, whereas EphB2 tyrosine kinase activity regulates cell proliferation through an Abl-cyclin D1 pathway. Cyclin D1 regulation becomes uncoupled from EphB signaling during the progression from adenoma to colon carcinoma in humans, allowing continued proliferation with invasive growth. The dissociation of EphB2 signaling pathways enables the selective inhibition of the mitogenic effect without affecting the tumor suppressor function and identifies a pharmacological strategy to suppress adenoma growth.
Science | 2013
Hanna Sabelström; Moa Stenudd; Pedro Réu; David O. Dias; Marta Elfineh; Sofia Zdunek; Peter Damberg; Christian Göritz; Jonas Frisén
The Good Scar We tend to think of scars as bad and, in the central nervous system, as counterproductive to recovery. Studying mice, Sabelström et al. (p. 637) prevented resident stem cells from proliferating after spinal cord injury. Without the astrocytes generated by the neural stem cells, recovery from spinal cord lesions was poorer than normal. Thus, somewhat counterintuitively, glial scarring appears to limit spinal cord damage and support the remaining cells. Glial scarring helps to maintain the integrity of the injured spinal cord in mice. Central nervous system injuries are accompanied by scar formation. It has been difficult to delineate the precise role of the scar, as it is made by several different cell types, which may limit the damage but also inhibit axonal regrowth. We show that scarring by neural stem cell–derived astrocytes is required to restrict secondary enlargement of the lesion and further axonal loss after spinal cord injury. Moreover, neural stem cell progeny exerts a neurotrophic effect required for survival of neurons adjacent to the lesion. One distinct component of the glial scar, deriving from resident neural stem cells, is required for maintaining the integrity of the injured spinal cord.
Experimental Cell Research | 2011
Olaf Bergmann; Sofia Zdunek; Kanar Alkass; Henrik Druid; Samuel Bernard; Jonas Frisén
Assays to quantify myocardial renewal rely on the accurate identification of cardiomyocyte nuclei. We previously ¹⁴C birth dated human cardiomyocytes based on the nuclear localization of cTroponins T and I. A recent report by Kajstura et al. suggested that cTroponin I is only localized to the nucleus in a senescent subpopulation of cardiomyocytes, implying that ¹⁴C birth dating of cTroponin T and I positive cell populations underestimates cardiomyocyte renewal in humans. We show here that the isolation of cell nuclei from the heart by flow cytometry with antibodies against cardiac Troponins T and I, as well as pericentriolar material 1 (PCM-1), allows for isolation of close to all cardiomyocyte nuclei, based on ploidy and marker expression. We also present a reassessment of cardiomyocyte ploidy, which has important implications for the analysis of cell turnover, and iododeoxyuridine (IdU) incorporation data. These data provide the foundation for reliable analysis of cardiomyocyte turnover in humans.
Nature Neuroscience | 2014
Hagen B. Huttner; Olaf Bergmann; Mehran Salehpour; Attila Rácz; Emma Lindgren; Tamás Csonka; László Csiba; Tibor Hortobágyi; Gábor Méhes; Elisabet Englund; Beata Werne Solnestam; Sofia Zdunek; Christian Scharenberg; Lena Ström; Patrik L. Ståhl; Benjamín Sigurgeirsson; Andreas Dahl; Stefan Schwab; Göran Possnert; Samuel Bernard; Zaal Kokaia; Olle Lindvall; Joakim Lundeberg; Jonas Frisén
It has been unclear whether ischemic stroke induces neurogenesis or neuronal DNA rearrangements in the human neocortex. Using immunohistochemistry; transcriptome, genome and ploidy analyses; and determination of nuclear bomb test–derived 14C concentration in neuronal DNA, we found neither to be the case. A large proportion of cortical neurons displayed DNA fragmentation and DNA repair a short time after stroke, whereas neurons at chronic stages after stroke showed DNA integrity, demonstrating the relevance of an intact genome for survival.
Circulation Research | 2012
Olaf Bergmann; Sofia Zdunek; Jonas Frisén; Samuel Bernard; Henrik Druid; Stefan Jovinge
To the Editor: In a recent review article by Leri, Kajstura, and Anversa1 in Circulation Research , there are several misrepresentations and factual errors in the description of our study on birth dating of heart cells.2 These errors affect their conclusions, and it is thus important to make some clarifications. First, Leri et al1 claim that we analyzed 12 pathological hearts, which is incorrect. Briefly, only 1 of the 12 studied subjects had a history of cardiac disease (a previous myocardial infarction) and was the only individual who had heart enlargement or any medication for cardiovascular disease (nitrates). Another individual died of acute myocardial infarction and displayed myocardial hypertrophy and moderate coronary sclerosis at autopsy. Of the remaining 10 individuals, 4 had slight myocardial hypertrophy, slight coronary sclerosis, and/or slight fibrosis detected at autopsy, and 1 of these had hypertension. The remaining 6 of the 12 studied individuals had neither a history of cardiovascular disease nor any sign of cardiac pathology at autopsy. Detailed information, including all of the above, was provided in our original study (Table S2), and we addressed the potential role of cardiac pathology in some of the included cases in our original publication.2 Second, Leri et al1 claim that we assessed the birth date of a …
Archive | 2015
Sofia Zdunek
Circulation Research | 2011
Olaf Bergmann; Sofia Zdunek; Mehran Salehpour; Samuel Bernard; Staffan Sjöström; Karl Håkansson; Kanar Alkass; Henrik Druid; Göran Possnert; Jonas Frisén